Quotient Sciences Miami
Miami, Florida, United States
Pharmaceutical company in Miami, Florida
3898 NW 7th St, Miami, FL 33126
About Quotient Sciences Miami
"Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway for small molecule & peptide drug programs. Cutting through silos across a range of drug development capabilities, we help pharma and biotech companies get new therapies to patients, fast."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Bristol-Myers Squibb
3
Satsuma Pharmaceuticals, Inc.
2
Altor BioScience
1
Angion Biomedica Corp
1
Cerecin
1
Daiichi Sankyo, Inc.
1
Drugs for Neglected Diseases
1
Eagle Pharmaceuticals, Inc.
1
Endevica Bio
1
Ensysce Biosciences
1
Clinical Trials at Quotient Sciences Miami
During the past decade, Quotient Sciences Miami conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration
2017-11-30
2018-07-12
Completed
600
QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803
2018-01-08
2018-03-13
Completed
20
A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
2018-09-21
2018-11-23
Completed
12
Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence
2018-07-31
2018-12-15
Completed
13
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
2018-10-03
2018-11-12
Completed
48
A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
2018-09-11
2018-11-07
Completed
46
Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids
2019-08-09
2019-10-16
Completed
29
A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants
2019-10-23
2020-01-09
Completed
15
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Quotient Sciences Miami" #1 sponsor was "Pfizer" with 5 trials, followed by "Bristol-Myers Squibb" with 3 trials
sponsored, "Satsuma Pharmaceuticals, Inc." with 2 trials sponsored, "Altor BioScience" with 1 trials sponsored and "Angion Biomedica Corp"
with 1 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Quotient Sciences Miami"
#1 collaborator was "Quotient Sciences" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Quotient Sciences Miami
According to Clinical.Site data, the most researched conditions in "Quotient Sciences Miami" are
"Healthy" (5 trials), "Healthy Participants" (4 trials), "Migraine" (2 trials), "Migraine With Aura" (2 trials) and "Migraine Without Aura" (2 trials). Many other conditions were trialed in "Quotient Sciences Miami" in a lesser frequency.
Clinical Trials Intervention Types at Quotient Sciences Miami
Most popular intervention types in "Quotient Sciences Miami" are "Drug" (21 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Dihydroergotamine" (2 trials), "PF-06651600" (2 trials), "AC-OLE-01-VA" (1 trials) and "ALT-803" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Quotient Sciences Miami
The vast majority of trials in "Quotient Sciences Miami" are
15 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Quotient Sciences Miami
Currently, there are NaN active trials in "Quotient Sciences Miami".
1 are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Quotient Sciences Miami,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Quotient Sciences Miami, 21 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".